Plain-English translation of NCT07634770 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 1 research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a new medication called SCD0503—an insulin pill that you swallow instead of inject. Researchers want to see how well this medication works compared to regular insulin injections, how your body absorbs it, and whether eating food affects how it works. The active ingredient is regular human insulin, which has been safely used in diabetes treatment for many years.
Currently, people with type 1 diabetes must inject insulin multiple times a day. This trial exists to see if an oral (pill) version could work just as well, which might make diabetes management easier and less painful for patients.
You likely qualify if…
You likely don't qualify if…
You will visit the research clinic 8 times over 1 to 4 months. During most visits, you'll receive either the new medication or a standard insulin injection, then have your blood sugar monitored closely using a special device called a 'clamp' that keeps your blood sugar stable, or you'll eat a standard breakfast and have your blood sugar measured afterward. You'll have catheters (small tubes) placed in your arms to take blood samples and give you glucose or insulin if needed during the visits. Different participants will receive the treatments in different orders to help researchers understand how the medication works.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Germany